Heidelberg Pharma AG (LON:0QW5)
2.640
0.00 (0.00%)
At close: Apr 14, 2025
Heidelberg Pharma AG Revenue
In the fiscal year ending November 30, 2024, Heidelberg Pharma AG had annual revenue of 6.85M EUR, down -30.53%. Heidelberg Pharma AG had revenue of 1.60M in the quarter ending November 30, 2024, a decrease of -50.33%.
Revenue
6.85M EUR
Revenue Growth
-30.53%
P/S Ratio
19.51
Revenue / Employee
65.23K EUR
Employees
105
Market Cap
111.00M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2024 | 6.85M | -3.01M | -30.53% |
Nov 30, 2023 | 9.86M | -8.66M | -46.75% |
Nov 30, 2022 | 18.51M | 16.48M | 810.30% |
Nov 30, 2021 | 2.03M | -6.63M | -76.53% |
Nov 30, 2020 | 8.67M | 1.17M | 15.63% |
Nov 30, 2019 | Pro | Pro | Pro |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
British American Tobacco p.l.c. | 25.87B |
London Stock Exchange Group | 8.86B |